Press "Enter" to skip to content

Carl Icahn takes aim at genome sequencer Illumina over Grail deal

https://www.ft.com/content/653c4d1c-d5cf-406c-b2e8-fa24ee453153
Company’s shares jump 21 per cent after activist investor launches proxy battle…

More from BusinessMore posts in Business »
More from UncategorizedMore posts in Uncategorized »